Innovation Theater

Providers Discuss a Novel LAI Treatment Option for Schizophrenia or maintenance treatment for Bipolar I Disorder in Appropriate Adult Patients

Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Presenter(s):
Erin C. Crown, PA-C
Greg Mattingly, MD
Roger S. McIntyre, MD, FRCPC

This presentation is provided by Otsuka America Pharmaceutical, Inc. and Lundbeck